Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

meningococcal conjugate vaccine

meningococcal conjugate vaccine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Menveo POWDER FOR INJECTION, INTRAMUSCULAR 0.5 mL      
Menactra SOLUTION, INTRAMUSCULAR 0.5 mL    
MenQuadfi SOLUTION, INTRAMUSCULAR 0.5 mL    
Nimenrix SOLUTION, INTRAMUSCULAR 0.5 mL    
VIEW MORE Vaccines
CLASS
801200
Comments:

Meningococcal Vaccine Guidelines

If an order is received for 'meningococcal vaccine', dispense MENVEO (MenACWY) for patients > 2 years of age. MENVEO may be used in patients > 55 years of age.

 

MENACTRA and MENVEO are currently available latex-free.

Nimenrix is not available in the United States as of October 2024.

 

See Meningococcal Vaccine Guidelines for dosing and administration instructions.

Reviewed: February 26, 2008, October 26, 2010 and June 2018 (Vaccine Contract), October 2024 (Nimenrix & MenQuadfi)

MEN-ACWY vaccines (Nimenrix and MenQuadfi) Spotlights.pdf

Last updated: Dec. 24, 2024






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved